This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Daugherty, A. Articles by Cassis, L. A. Search for Related Content PubMed PubMed Citation Articles by Daugherty, A. Articles by Cassis, L. A. Social Bookmarking                   What's this?

Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin converting enzyme inhibitors and aortic rupture: population based case control study. Lancet. 2006;368:659-665

Cardiovascular Research Center University of Kentucky Lexington, Kentucky

Lisa A. Cassis, PhD

Graduate Center for Nutritional Sciences University of Kentucky Lexington, Kentucky

Background: Angiotensin-converting enzyme (ACE) inhibitors prevent the expansion and rupture of aortic aneurysms in animals. We investigated the association between ACE inhibitors and rupture in patients with abdominal aortic aneurysms.

Methods: We did a population-based case-control study of linked administrative databases in Ontario, Canada. The sample included consecutive patients older than 65 (n = 15 326) admitted to hospital with a primary diagnosis of ruptured or intact abdominal aortic aneurysm between April 1, 1992, and April 1, 2002.

Findings: Patients who received ACE inhibitors before admission were significantly less likely to present with ruptured aneurysm (odds ratio [OR] 0.82, 95% CI 0.74—0.90) than those who did not receive ACE inhibitors. Adjustment for demographic characteristics, risk factors for rupture, comorbidities, contraindications to ACE inhibitors, measures of health-care use, and aneurysm screening yielded similar results (0.83, 0.73—0.95). Consistent findings were noted in subgroups at high risk of rupture, including patients older than 75 years and those with a history of hypertension. Conversely, such protective associations were not observed for ß blockers (1.02, 0.89—1.17), calcium channel blockers (1.01, 0.89—1.14), blockers (1.15, 0.86—1.54), angiotensin receptor blockers (1.24, 0.71—2.18), or thiazide diuretics (0.91, 0.78—1.07).

Interpretation: ACE inhibitors are associated with a reduced risk of ruptured abdominal aortic aneurysm, unlike other antihypertensive agents. Randomised trials of ACE inhibitors for prevention of aortic rupture might be warranted.

Key Words: ACE inhibitor • abdominal aortic aneurysm • matrix metalloproteinase • database analysis

Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 19, No. 3, 342-344 (2007)
DOI: 10.1177/1531003507305927


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?